James Peyer PhD

James Peyer is the Founder and Managing Partner of Kronos BioVentures, a biotechnology fund investing in breakthrough therapeutics that affect fundamental mechanisms of our natural degeneration we call aging. Kronos founds invests and builds biotech companies. He created Kronos to explore the potential of our newfound knowledge of what makes us age, believing that medicines derived from this knowledge will enable the greatest medical breakthroughs of the 21st century.

James is a widely recognized speaker and educator on the topic of longevity biotech investing and has worked with the Economist, TEDx, Longevity Leaders, MasterInvestor and many others to drive the conversation about developing longevity therapeutics in our lifetime. He has been a guest lecturer at ETH Zurich and the Max Planck Institute.

Before Kronos James founded and built Apollo Ventures, a life science investment arm of a group of impact-minded family offices in Europe. He built Apollo from its founding to be one of the world's leading investors in longevity biotech. He led investments in Cleara Biotech, Aeonian Pharmaceuticals, and Samsara Therapeutics.

Before Apollo, James worked as a McKinsey consultant, earned his doctorate at UTSW as a National Science Foundation Fellow, and got his undergraduate with special honors from the University of Chicago.